HealthEquity, Inc. (NASDAQ:HQY) Q3 2025 Earnings Conference Call December 9, 2024 4:30 PM ET

Company Participants

Richard Putnam - IR
Jon Kessler - President and CEO
James Lucania - EVP and CFO
Steve Neeleman - Vice Chair and Founder
Scott Cutler - upcoming President and CEO

Conference Call Participants

Gregory Peters - Raymond James
Stan Berenshteyn - Wells Fargo
Glen Santangelo - Jefferies
Allen Lutz - Bank of America
Anne Samuel - JPMorgan
George Hill - Deutsche Bank
Mark Marcon - Baird
David Roman - Goldman Sachs
David Larsen - BTIG
Steven Valiquette - Mizuho Securities
Sean Dodge - RBC Capital Markets

Operator

Good afternoon, and welcome to the HealthEquity Third Quarter 2025 Earnings Conference Call. Please note this event is being recorded.

I would now like to turn the conference over to Richard Putnam. Please go ahead.

Richard Putnam

Thank you, Nick. Hello, everyone. Welcome to HealthEquity's third quarter of fiscal year 2025 earnings conference call. My name is Richard Putnam, Investor Relations for HealthEquity. And joining me today is Jon Kessler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the company; and James Lucania, Executive Vice President and CFO; Scott Cutler, recently appointed successor President and CEO beginning in January.

Before I turn the call over to Jon, I have a couple of reminders. First, a press release announcing the financial results for our third quarter of fiscal 2025 was issued after the market closes this afternoon. These financial results include the contributions of our wholly-owned subsidiaries and accounts they administer.

Press release includes definitions of certain non-GAAP financial measures that we will reference here today where you can find on our Investor Relations website a copy of today's press release, including reconciliations of these non-GAAP measures with comparable GAAP measures and a recording of this webcast. The website is ir.healthequity.com.

Second, our comments and responses to your questions today reflect the management's view as of today, December 9th, 2024, and will contain forward-looking statements as defined by the SEC, including predictions, expectations, estimates, or other information that might be considered forward-looking. There are many important factors relating to our business which could affect the forward-looking statements made today. These forward-looking statements are subject to risk and uncertainties that may cause our actual results to differ materially from statements made here today.

We caution against placing undue reliance on these forward-looking statements, and we also encourage you to review the discussion of these factors and other risks that may affect our future results or the market price of our stock, as detailed in our latest annual report on Form 10-K and in subsequent periodic reports filed with the SEC. We assume no obligation to revise or update these forward-looking statements in light of new information or future events.